Dr. Mohammed Chowdhury Provides Perspective to MedPage Today on New Drug to Prevent Worsening Pulmonary Arterial Hypertension

Mohammed Andaleeb Chowdhury, MD, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to MedPage Today on data from an international phase III trial that found oral ralinepag significantly reduced the risk of first clinical worsening in low-risk patients with pulmonary arterial hypertension already receiving contemporary background therapy.